Cell viability assays showed that CMTM6 promoted the sensitivity of HCC cells to Dox and DDP and decreased their half maximal inhibitory concentration (IC50) value, whereas inverse regulation of p21 expression could reverse the effect of CMTM6 on Dox and DDP sensitivity. The gene discussed is CDKN1A; the disease is hepatocellular carcinoma.